Invitrogen Reaches Key Milestone in its Agreement with Blue Heron Biotechnology
News Oct 19, 2007
Invitrogen Corporation has reached a key milestone in its agreement with Blue Heron Biotechnology and is now the co-exclusive worldwide distributor with Blue Heron for its custom gene synthesis services.
Blue Heron Biotechnology says that its proprietary GeneMaker® platform can synthesize gene sequences with perfect accuracy which makes it ideal for researchers studying anything from single genes up to entire genomes as in the biofuels and synthetic biology markets.
Researchers worldwide are increasingly turning to synthetic genes as a convenient, cost-effective alternative for traditional cloning. Synthetic genes have allowed pharmaceutical and biotechnology companies to speed the drug discovery process by rapidly and accurately synthesizing genes of interest that are in turn used to produce novel proteins, new vaccines and diagnostics.
"For decades, researchers have depended on Invitrogen's cloning platforms and gene collections to advance their gene discovery and functional genomics experiments. With new technologies that allow the economical production of synthetic genes, researchers can expand the possibilities of science," said Dr. Balwant Patel, general manager for Cloning and Protein Expression at Invitrogen.
"Our relationship with Blue Heron means that our customers will explore those possibilities with the best synthetic genetics technologies and the most highly regarded cloning and expression platforms available commercially," Dr. Patel added.
"This relationship creates unique opportunities to serve the needs of the research community. We are very enthusiastic about bringing Blue Heron's technological leadership in gene synthesis to Invitrogen's unmatched worldwide customer base," said John Fess, CEO of Blue Heron.
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE
Hidden Signals in RNAs Regulate Protein SynthesisNews
Scientists have long known that RNA encodes instructions to make proteins. In a new study published in Nature, scientists describe how the protein-making machinery identifies alternative initiation sites from which to start protein synthesis.READ MORE
ExPecto Patronum! Magical Machine Learning Tool Summons DNA Dark Matter DataNews
A new machine learning framework, dubbed ExPecto, can predict the effects of mutations in the so-called “dark matter” regions of the human genome. ExPecto pinpoints how mutations can disrupt the way genes turn on and off throughout your body.